These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 23290951)
1. Current evidence for monitoring platelet reactivity in acute coronary syndrome: a plea for individualized antiplatelet treatment. Aradi D; Sibbing D; Bonello L Int J Cardiol; 2013 Sep; 167(5):1794-7. PubMed ID: 23290951 [TBL] [Abstract][Full Text] [Related]
2. A model-based analysis of the clinical and economic impact of personalising P2Y12-receptor inhibition with platelet function testing in acute coronary syndrome patients. Straub N; Beivers A; Lenk E; Aradi D; Sibbing D Thromb Haemost; 2014 Feb; 111(2):290-9. PubMed ID: 24154566 [TBL] [Abstract][Full Text] [Related]
4. New antiplatelet agents and the role of platelet function testing in acute coronary syndromes. Sinhal AR; Aylward PE Clin Ther; 2013 Aug; 35(8):1064-8. PubMed ID: 23973039 [TBL] [Abstract][Full Text] [Related]
5. Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors. Winter MP; Grove EL; De Caterina R; Gorog DA; Ahrens I; Geisler T; Gurbel PA; Tantry U; Navarese EP; Siller-Matula JM Eur Heart J Cardiovasc Pharmacother; 2017 Oct; 3(4):221-234. PubMed ID: 28204303 [TBL] [Abstract][Full Text] [Related]
6. Potent P2Y12 receptor inhibitors in patients with acute coronary syndrome. Agents, indications, issues to consider in clinical practice. Sibbing D; Orban M; Massberg S Hamostaseologie; 2013; 33(1):9-15. PubMed ID: 23299202 [TBL] [Abstract][Full Text] [Related]
8. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. Tantry US; Bonello L; Aradi D; Price MJ; Jeong YH; Angiolillo DJ; Stone GW; Curzen N; Geisler T; Ten Berg J; Kirtane A; Siller-Matula J; Mahla E; Becker RC; Bhatt DL; Waksman R; Rao SV; Alexopoulos D; Marcucci R; Reny JL; Trenk D; Sibbing D; Gurbel PA; J Am Coll Cardiol; 2013 Dec; 62(24):2261-73. PubMed ID: 24076493 [TBL] [Abstract][Full Text] [Related]
9. Current Status of Antiplatelet Therapy in Acute Coronary Syndrome. Dash D Cardiovasc Hematol Agents Med Chem; 2015; 13(1):40-9. PubMed ID: 26245659 [TBL] [Abstract][Full Text] [Related]
10. Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study. Alexopoulos D; Galati A; Xanthopoulou I; Mavronasiou E; Kassimis G; Theodoropoulos KC; Makris G; Damelou A; Tsigkas G; Hahalis G; Davlouros P J Am Coll Cardiol; 2012 Jul; 60(3):193-9. PubMed ID: 22789884 [TBL] [Abstract][Full Text] [Related]
11. Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors? Kowalczyk M; Banach M; Mikhailidis DP; Hannam S; Rysz J Med Sci Monit; 2009 Dec; 15(12):MS24-30. PubMed ID: 19946242 [TBL] [Abstract][Full Text] [Related]
12. Novel platelet ADP P2Y12 inhibitors in the treatment of acute coronary syndrome. Tan GM; Lam YY; Yan BP Cardiovasc Ther; 2012 Aug; 30(4):e167-73. PubMed ID: 21883998 [TBL] [Abstract][Full Text] [Related]
13. Platelet function monitoring in patients on clopidogrel: What should we learn from GRAVITAS? Aradi D; Komócsi A Platelets; 2012; 23(3):167-76. PubMed ID: 21958190 [TBL] [Abstract][Full Text] [Related]
14. Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome. Packard KA; Campbell JA; Knezevich JT; Davis EM Pharmacotherapy; 2012 Mar; 32(3):244-73. PubMed ID: 22392457 [TBL] [Abstract][Full Text] [Related]
15. Is platelet inhibition correlated with time from last intake on P2Y12 blockers after an acute coronary syndrome? A pilot study. Deharo P; Quilici J; Bonnet G; Grosdidier C; Morange P; Alessi MC; Bonnet JL; Cuisset T Platelets; 2016 Dec; 27(8):791-795. PubMed ID: 27275528 [TBL] [Abstract][Full Text] [Related]